Recently it was shown that TGF-β2 was upregulated in the DTCs isolated from PCa patients that had no evidence of disease from 7–18 years after radical prostatectomy, compared to DTCs from patients with active PCa metastatic disease14. The gene discussed is TGFB2; the disease is posterior cortical atrophy.